Responses
Concise report
The tumour necrosis factor receptor superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis
Compose a Response to This Article
Other responses
No responses have been published for this article.